Td Asset Management Inc Lyell Immunopharma, Inc. Transaction History
Td Asset Management Inc
- $106 Billion
- Q4 2024
A detailed history of Td Asset Management Inc transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 1,004,642 shares of LYEL stock, worth $542,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,004,642
Previous 1,004,642
-0.0%
Holding current value
$542,506
Previous $1.39 Million
53.68%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LYEL
# of Institutions
108Shares Held
171MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$10.9 Million17.35% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$8.15 Million14.08% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$8.15 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$7.29 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$6.43 Million1.63% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $134M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...